Key result
Catheter ablation effectively reduces ventricular tachycardia episodes and ICD shocks in patients with structural heart disease, and is often curative as a sole therapy for idiopathic ventricular tachycardia.
This review highlights catheter ablation as an effective treatment for ventricular arrhythmias, reducing VT episodes and ICD shocks in structural heart disease and serving as sole therapy in structurally normal hearts.
Supports ablation to reduce VT burden; leaves open need for RCTs in structural heart disease.
Catheter ablation has emerged as an important and effective treatment option for many recurrent ventricular arrhythmias. The approach to ablation and the risks and outcomes are largely determined by the nature of the severity and type of underlying heart disease. In patients with structural heart disease, catheter ablation can effectively reduce ventricular tachycardia (VT) episodes and implantable cardioverter defibrillator (ICD) shocks. For VT and symptomatic premature ventricular beats that occur in the absence of structural heart disease, catheter ablation is often effective as the sole therapy. Advances in catheter technology, imaging and mapping techniques have improved success rates for ablation. This review discusses current approaches to mapping and ablation for ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Nof et al. (2013) conducted a review in Ventricular Arrhythmias. Catheter Ablation was evaluated. Catheter ablation effectively reduces ventricular tachycardia episodes and ICD shocks in patients with structural heart disease, and is often curative as a sole therapy for idiopathic ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: